Haematuria after prostate brachytherapy

作者: Michael S. Leapman , Simon J. Hall , Nelson N. Stone , Richard G. Stock

DOI: 10.1111/J.1464-410X.2012.11697.X

关键词: Clinical historyProstate brachytherapyBrachytherapyProstateUrinary retentionClinical risk factorMedicineProstate cancerUrologyMultivariate analysis

摘要: What's known on the subject? and What does study add? Previous descriptions of haematuria after brachytherapy are limited. This characterizes long-term incidence associated clinical risk factors prostate brachytherapy. Objective To characterize history gross brachytherapy. To identify treatment for development in this setting. Patients Methods We reviewed outcomes collected prospectively 2454 patients treated with transperineal over a 20-year period at single institution. Patients were followed median 5.9 years. The association age, pretreatment PSA, ethnicity, tumour stage, Gleason score, volume, isotope (iodine 125 or palladium 103), biologically effective dose (BED), external beam radiation, androgen deprivation, urinary retention occurrence biochemical failure was investigated. Results A total 218 men (8.9%) reported time 772.2 days implantation. Haematuria volume >40 cm3 (P 7 = 0.037), Asian ethnicity 200 Gy 0.01), freedom from 0.004). On multivariate analysis, 0.002), 0.001), 0.035) predictors haematuria. Conclusions Late observed small proportion may occur considerable latency. Larger glands, radiation factors.

参考文章(14)
Richard G. Stock, Nelson N. Stone, PERMANENT RADIOACTIVE SEED IMPLANTATION IN THE TREATMENT OF PROSTATE CANCER Hematology-oncology Clinics of North America. ,vol. 13, pp. 489- 501 ,(1999) , 10.1016/S0889-8588(05)70070-8
Yasuo Yoshioka, Takayuki Nose, Ken Yoshida, Ryoong-Jin Oh, Yuji Yamada, Eiichi Tanaka, Hideya Yamazaki, Takehiro Inoue, Toshihiko Inoue, High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity. International Journal of Radiation Oncology Biology Physics. ,vol. 56, pp. 213- 220 ,(2003) , 10.1016/S0360-3016(03)00081-6
Nelson N. Stone, Naamit Kurshan Gerber, Seth Blacksburg, Jonathan Stone, Richard G. Stock, Factors Influencing Urinary Symptoms 10 Years After Permanent Prostate Seed Implantation Journal of Urology. ,vol. 187, pp. 117- 123 ,(2012) , 10.1016/J.JURO.2011.09.045
Brian J. Davis, Eric M. Horwitz, W. Robert Lee, Juanita M. Crook, Richard G. Stock, Gregory S. Merrick, Wayne M. Butler, Peter D. Grimm, Nelson N. Stone, Louis Potters, Anthony L. Zietman, Michael J. Zelefsky, American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy Brachytherapy. ,vol. 11, pp. 6- 19 ,(2012) , 10.1016/J.BRACHY.2011.07.005
N Stone, Complications following permanent prostate brachytherapy European Urology. ,vol. 41, pp. 427- 433 ,(2002) , 10.1016/S0302-2838(02)00019-2
M.A. KOLLMEIER, R.G. STOCK, J. CESARETTI, N.N. STONE, URINARY MORBIDITY AND INCONTINENCE FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE AFTER BRACHYTHERAPY The Journal of Urology. ,vol. 173, pp. 808- 812 ,(2005) , 10.1097/01.JU.0000152698.20487.0E
Jerry Barker, Kent Wallner, Gregory Merrick, Gross hematuria after prostate brachytherapy Urology. ,vol. 61, pp. 408- 411 ,(2003) , 10.1016/S0090-4295(02)02247-1
Mack Roach, Gerald Hanks, Howard Thames, Paul Schellhammer, William U. Shipley, Gerald H. Sokol, Howard Sandler, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference International Journal of Radiation Oncology*Biology*Physics. ,vol. 65, pp. 965- 974 ,(2006) , 10.1016/J.IJROBP.2006.04.029
John F. Anderson, David A. Swanson, Lawrence B. Levy, Deborah A. Kuban, Andrew K. Lee, Rajat Kudchadker, Jack Phan, Teresa Bruno, Steven J. Frank, Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology. ,vol. 74, pp. 601- 605 ,(2009) , 10.1016/J.UROLOGY.2009.04.060